MALVERN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies ...
Just one year after identifying early leads for its oral FSH program, Celmatix has nominated its first lead after the compound demonstrated oral bioavailability and biological activity in the gold ...
Leishmaniasis, a neglected tropical disease prevalent across 90 countries, affects approximately 12 million people worldwide, ...
Individual food compounds, rather than broad food groups, may have important effects on IBD disease activity. A machine learning model identified food compounds associated with modulating disease ...